Stephen Tung

More time, support, resources and know-how than any other seed-stage investor in Australia. Thats the value you dont see on a cheque.

TEN13 is a global VC fuelling founders with first cheques from $300k-$2m and support through the journey to scale. Backed by 650+ investors, founders and operators.

We’re on a mission to speed up health breakthroughs for everyone. Today, over 1 billion patients miss out on critical health breakthroughs because knowledge is scattered, overwhelming, and always changing. Turnto solves this by aggregating and delivering the most up-to-date and personalized insights for patients living with serious health conditions. Live now in backed by the founders of Canva and Google Maps, Turnto is live for Migraine, Stroke, Long Covid, MECFS, Parkinson’s, Epilepsy, MS, Endometriosis, Cerebral Palsy, ALS, Mast Cell Diseases, and Lupus. Built by patients, for patients.

More time, support, resources and know-how than any other seed-stage investor in Australia. Thats the value you dont see on a cheque.

TEN13 is a global VC fuelling founders with first cheques from $300k-$2m and support through the journey to scale. Backed by 650+ investors, founders and operators.

Antler is one of the most active early-stage investors globally. The firm leads in ‘Day Zero’ investing, an approach to venture capital focused on partnering with founders pre-launch. Antler systematically removes capital and network constraints for early-stage technology entrepreneurs by providing co-founder matching, deep business model validation, initial capital, expansion support, and follow-on funding. The firm is present in 27 cities across most leading technology ecosystems globally and has made over 1,300 investments into early-stage startups. Antler has been repeatedly recognized by Pitchbook as the world’s most active angel and seed-stage investor.

We’re on a mission to speed up health breakthroughs for everyone. Today, over 1 billion patients miss out on critical health breakthroughs because knowledge is scattered, overwhelming, and always changing. Turnto solves this by aggregating and delivering the most up-to-date and personalized insights for patients living with serious health conditions. Live now in backed by the founders of Canva and Google Maps, Turnto is live for Migraine, Stroke, Long Covid, MECFS, Parkinson’s, Epilepsy, MS, Endometriosis, Cerebral Palsy, ALS, Mast Cell Diseases, and Lupus. Built by patients, for patients.

PERPETUATE 🎯 ❇️The TL;DR version: We only work with specific Companies/Founders to win *un-winnable*, inaccessible, high pedigree Talent. Typically, that Talent has Silicon Valley/Bay Area or adjacent Pedigree. Except, now they live in Australia. We avoid Active Job Seekers. 🔘 The EXPANDED Version: 🟩 We attract world-class individual-contributor level engineering, engineering management AND management (of) engineering management TALENT. We do the same for Product, DevOps & Automation QA talent, too. 🟩 Hire (above) talent FOR genuine Silicon Valley GrowthTech companies; typically, unicorns of $10B+ USD market cap. 🟩 Hire (above) talent FOR carefully curated Australian Start/Scaleups - with structural duplication & alignment to - Silicon-Valley philosophy. MUST be engineering-native, not only tech native // (usually) product-native AND in high, or hyper-growth phase. We also prefer founder-led. 🟩 We bias towards deep, cutting-edge & complex tech – ideally with purposeful, positive societal mission orientation. 🟩 We CONNECT high calibre entrepreneurs to investors & peripheral services - within the AU x US ecosystems - who should know each other, but don’t. We believe in RECIPROCITY and intentional serendipity. So, we facilitate these intros mostly - for free. 🟩 We do an unparalleled volume of pre-diligence before partnering any represented individual, or company. 🟩 Bet on early high-conviction angel investments 🟩 Semi-regular Portfolio Events 🟩 We LOVE first-principle-thinking, and study patterns. And Signals. We ignore noise/hype. 🟩 A’s hire A’s // B’s hire C’s’ 🔘 Things We DONT Do: 🟥 We don’t advertise, and we don’t interview – not by the ‘traditional’ definition. In-demand, world-class engineering talent - are an aversion to the mean. Traditional interviewing formats net sub-optimal outcomes.